The dosage dependence of VEGF stimulation on scaffold neovascularisation
Standard
The dosage dependence of VEGF stimulation on scaffold neovascularisation. / Davies, Neil; Dobner, Stephan; Bezuidenhout, Deon; Schmidt, Christian; Beck, Michael; Zisch, Andreas H; Zilla, Peter.
In: BIOMATERIALS, Vol. 29, No. 26, 09.2008, p. 3531-3538.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - The dosage dependence of VEGF stimulation on scaffold neovascularisation
AU - Davies, Neil
AU - Dobner, Stephan
AU - Bezuidenhout, Deon
AU - Schmidt, Christian
AU - Beck, Michael
AU - Zisch, Andreas H
AU - Zilla, Peter
PY - 2008/9
Y1 - 2008/9
N2 - Growth factors are often used in tissue regeneration to stimulate vascularisation of polymeric scaffolds, with vascular endothelial growth factor (VEGF) having been extensively studied for short-term vessel ingrowth. We have therefore evaluated the effect of different concentrations of VEGF on the vascularisation of a porous scaffold in the short-, intermediate- and long-term, by delivering 15, 150 and 1500ng VEGF/day to polyurethane scaffolds by osmotic pumps for up to 6 weeks. An increased vascularisation months after termination of VEGF delivery was only achieved with 150ng/day (46%, p<0.05). This dosage consistently showed elevated levels of vascularisation (144, 125, 160 and 60% above PBS controls at 10, 20, 30 and 42 days, respectively, p<0.05), whilst the vessels induced by the highest dosage, though initially maximally elevated (265 and 270% at 10 and 20 days, p<0.05) tended to regress after 20 days of VEGF delivery. Pericyte coverage was decreased at 20 days for the highest dosage (30%, p<0.05). Lectin perfusion demonstrated that vessels within the scaffold were connected to the host vasculature at all time points and perfusion was substantially raised by VEGF delivery at day 20. These results suggest concentration of VEGF plays a critical role in the nature and persistence of vasculature formed in a tissue regenerative scaffold.
AB - Growth factors are often used in tissue regeneration to stimulate vascularisation of polymeric scaffolds, with vascular endothelial growth factor (VEGF) having been extensively studied for short-term vessel ingrowth. We have therefore evaluated the effect of different concentrations of VEGF on the vascularisation of a porous scaffold in the short-, intermediate- and long-term, by delivering 15, 150 and 1500ng VEGF/day to polyurethane scaffolds by osmotic pumps for up to 6 weeks. An increased vascularisation months after termination of VEGF delivery was only achieved with 150ng/day (46%, p<0.05). This dosage consistently showed elevated levels of vascularisation (144, 125, 160 and 60% above PBS controls at 10, 20, 30 and 42 days, respectively, p<0.05), whilst the vessels induced by the highest dosage, though initially maximally elevated (265 and 270% at 10 and 20 days, p<0.05) tended to regress after 20 days of VEGF delivery. Pericyte coverage was decreased at 20 days for the highest dosage (30%, p<0.05). Lectin perfusion demonstrated that vessels within the scaffold were connected to the host vasculature at all time points and perfusion was substantially raised by VEGF delivery at day 20. These results suggest concentration of VEGF plays a critical role in the nature and persistence of vasculature formed in a tissue regenerative scaffold.
KW - Animals
KW - Blood Vessels/cytology
KW - Dose-Response Relationship, Drug
KW - Neovascularization, Physiologic/drug effects
KW - Tissue Engineering
KW - Tissue Scaffolds
KW - Vascular Endothelial Growth Factor A/metabolism
U2 - 10.1016/j.biomaterials.2008.05.007
DO - 10.1016/j.biomaterials.2008.05.007
M3 - SCORING: Journal article
C2 - 18541296
VL - 29
SP - 3531
EP - 3538
JO - BIOMATERIALS
JF - BIOMATERIALS
SN - 0142-9612
IS - 26
ER -
